期刊文献+

老年社区获得性肺炎住院患者的临床资料分析 被引量:66

Clinical analysis of community-acquired pneumonia in the elderly
原文传递
导出
摘要 目的总结老年社区获得性肺炎(CAP)患者的临床表现、病原学及预后相关资料。方法回顾性分析2002年1月-2006年1月中山大学附属第三医院收治的成人 CAP 患者的临床资料,比较老年 CAP 患者(年龄>65岁)与中青年 CAP 患者(年龄≤65岁)临床特征的异同。结果成人 CAP 患者302例,年龄(68±21)岁。老年 CAP 患者216例,其中67.1%的患者合并基础疾病,175例(81.0%)患者在 Fine 危险分级Ⅳ~Ⅴ级,住院病死率为12.0%。肺炎链球菌仍是老年 CAP 患者最主要的致病菌。与86例中青年 CAP 患者相比,老年 CAP 患者入院时出现呼吸困难、急性意识障碍、心率增快及呼吸急促的比例明显增多,病原体分布与中青年 CAP 患者存在差异。结论老年CAP 患者发病率高、并发症多、预后差。临床表现、病原学具有其特殊性,应予足够重视。 Objectives To evaluate the clinical features, etiology, and outcome of patients over 65 years old hospitalized for community-acquired pneumonia(CAP). Methods A retrospective cohort analysis was performed for adult patients hospitalized with CAP in a 1000-bed teaching hospital between Jan 2002 and Jan 2006. Differences between≤65 yrs and 〉 65 yrs groups were calculated using X2 test. Results A total of 302 patients ( 166 males), with a mean age of (68 ± 21 ) yrs, were enrolled. Of the 216 elderly patients, 67.1% had comorbid conditions, mostly cardiovascular diseases and chronic obstructive lung disease. For the risk stratification, 175 patients were classified as Ⅳ - Ⅴ according to Fine's index. The mean hospital stay was 12 days and in-hospital mortality was 12.0%. The most frequent pathogen was Streptococcus pneumoniae in elderly patients. As compared to 86 younger patients (≤ 65yrs), altered mental status, dyspnea, tachypnea and tachycardia on hospital admission were more frequent in the elderly. The etiological distribution was also different between the two groups. Conclusions CAP in elderly patients is a prevalent disease with high incidence of complications and mortality. More attention should be paid to the specific clinical manifestations of this patient population.
出处 《中华内科杂志》 CAS CSCD 北大核心 2007年第10期810-814,共5页 Chinese Journal of Internal Medicine
关键词 社区获得性肺炎 老年 临床特征 Community-acquired pneumonia Elderly Clinic characteristics
  • 相关文献

参考文献15

  • 1社区获得性肺炎诊断和治疗指南(草案)[J].中华结核和呼吸杂志,1999,22(4):199-201. 被引量:1037
  • 2Fine MJ, Auble TE, Yealy DM ,et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med, 1997,336:243-250,
  • 3Kaplan V, Angus DC, Griffin MF, et al. Hospitalized community- acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States.Am J Respir Crit Care Med ,2002,165:766-772.
  • 4Janssens JP. Pneumonia in the elderly (geriatric) population. Curr Opin Pulm Med,2005,11:226-230.
  • 5Ewig S, Kleinfeld T, Bauer T, et al. Comparative validation of prognostic rules for community-acquired pneumonia in an elderly population. Eur Respir J, 1999,14 : 370-375,
  • 6Fine MJ, Smith MA, Carson CA ,et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA, 1996,275 : 134-141.
  • 7Angus DC, Marrie TJ, Obrosky DS, et al. Severe community- acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. Am J Respir Crit Care Med, 2002,166:717-723.
  • 8Venkatesan P, Gladman J, Macfarlane JT, et al. A hospital study of community acquired pneumonia in the elderly. Thorax, 1990, 45:254-258.
  • 9Riquelme R, Torres A, el-Ebiary M, et al. Community-acquired pneumonia in the elderly. Clinical and nutritional aspects. Am J Respir Crit Care Med, 1997,156 : 1908-1914.
  • 10Janssens JP, Krause KH.Pneumonia in the very old. Lancet Infect Dis, 2004,4 : 112-124.

二级参考文献24

  • 1Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 2Lepow ML,Balassanian N,Emmerich J,et al.Interrelationships of viral,mycoplasmal,and bacterial agents in uncomplicated pneumonia.Am Rev Respir Dis,1968,97:533-545.
  • 3Lim WS,Macfarlane JT,Boswell TC,et al.Study of community acquired pneumonia aetiology(SCAPA) in adults admitted to hospital:implications for management guidelines.Thorax,2001,56:296-301.
  • 4Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
  • 5Heffelfinger JD,Dowell SF,Jorgensen JH,et al.Management of community-acquired pneumonia in the era of pneumococcal resistance:a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.Arch Intern Med,2000,160:1399-1408.
  • 6Blasi F,Legnani D,Lombardo VM,et al.Chlamydia pneumoniae infection in acute exacerbations of COPD.Eur Respir J,1993,6:19-22.
  • 7Von Hertzen L,Alakarppa H,Koskinen R,et al.Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease.Epidemiol Infect,1997,118:155-164.
  • 8Takehana Y,Hamano S,Kikuchi S,et al.Inhibitory action of OKY-O46.HCl,a specific TXA2 synthetase inhibitor,on platelet activating factor (PAF)-induced airway hyperresponsiveness of guinea pigs:role of TXA2 in development of PAF-induced nonspecific airway h
  • 9Cosio M,Ghezzo H,Hogg JC,et al.The relations between structural changes in small airways and pulmonary-function tests.N Engl J Med,1978,298:1277-1281.
  • 10Tong CY,Sillis M.Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR.J Clin Pathol,1993,46:313-317.

共引文献1771

同被引文献439

引证文献66

二级引证文献398

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部